Medical Research and Edwards Lifesciences

Selected news for the healthcare topic - Medical Research, and the company - Edwards Lifesciences. We have 2,889 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/15/2022 Kidder Stephen W Purchases New Shares in Edwards Lifesciences Co. (NYSE:EW) - American Banking News American Banking News Kidder Stephen W bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW) during the third quarter, according to its most recent filing with the SEC. The fund bought 10,105 shares of the medical research company‚Aos stock, valued at approximately $1,144,000.Other hedge funds and other institutional investors have also modified their holdings of the company. West Oak Capital LLC purchased a new stake in Edwards Lifesciences ...
1/1/2022 Bbva USA Has $307,000 Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - Mayfield Recorder Mayfield Recorder Bbva USA trimmed its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 35.9% in the third quarter, Holdings Channel.com reports. The firm owned 2,712 shares of the medical research company‚Aos stock after selling 1,518 shares during the quarter. Bbva USA‚Aos holdings in Edwards Lifesciences were worth $307,000 at the end of the most recent reporting period.A number of other hedge funds also recently added to ...
12/31/2021 Xponance Inc. Lowers Stake in Edwards Lifesciences Co. (NYSE:EW) - The Cerbat Gem Xponance Inc. lessened its holdings in Edwards Lifesciences Co. (NYSE:EW) by 2.3% in the 3rd its most recent 13F filing with the Securities & Exchange Commission. The firm owned 125,438 shares of the medical research company‚Aos stock after selling 2,995 Xponance Inc.‚Aos holdings in Edwards Lifesciences were worth $14,201,000 as of its most recent SEC filing.A number of other hedge funds have also modified their holdings of ...
12/21/2021 Edwards Lifesciences (NYSE:EW) Upgraded to Overweight at JPMorgan Chase & Co. - Stock Observer JPMorgan Chase & Co. upgraded shares of Edwards Lifesciences (NYSE:EW) from a neutral rating to an overweight rating in a research note released on Friday morning, Analyst Price Targets reports. They currently have $140.00 target price on the medical research company‚Aos stock, up from their prior target price of $114.00.A number of other brokerages have also weighed in on EW. Citigroup upgraded shares of Edwards Lifesciences from a ...
12/20/2021 Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by JPMorgan Chase & Co. JPMorgan Chase & Co. upgraded shares of Edwards Lifesciences (NYSE:EW) from a neutral rating to an overweight rating in a research note released on Friday morning, Price Targets.com reports. They currently have $140.00 target price on the medical research company‚Aos stock, up from their previous target price of $114.00.EW has been the subject of a number of other reports. Jefferies Financial Group increased their price objective on Edwards ...
12/19/2021 Quest Capital Management Inc. ADV Increases Stake in Edwards Lifesciences Co. (NYSE:EW) Quest Capital Management Inc. ADV grew its holdings in Edwards Lifesciences Co. (NYSE:EW) by 2.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,132 shares of the medical research company‚Aos stock after buying an additional 127 shares during the quarter. Quest Capital Management Inc. ADV‚Aos holdings in Edwards Lifesciences were worth $694,000 as of ...
12/17/2021 Edwards Lifesciences (NYSE:EW) Rating Increased to Overweight at JPMorgan Chase & Co. - Slater Sentinel Edwards Lifesciences (NYSE:EW) was upgraded by equities research analysts at JPMorgan Chase & Co. from a ‚Auneutral‚Au rating to an ‚Auoverweight‚Au rating in a research report issued to clients and investors on Friday, The Fly reports. The brokerage presently has a $140.00 target price on the medical research company‚Aos stock, up from their prior target price of $114.00. JPMorgan Chase & Co. ‚Aos price objective points to a ...
12/16/2021 Phoenix Holdings Ltd. Makes New $616,000 Investment in Edwards Lifesciences Co. (NYSE:EW) - Ticker Report Ticker Report Phoenix Holdings Ltd. bought a new position in Edwards Lifesciences Co. (NYSE:EW) during the 3rd quarter, Holdings Channel.com reports. The fund bought 5,446 shares of the medical research company‚Aos stock, valued at approximately $616,000.Other hedge funds and other institutional investors also recently bought and sold shares of the company. Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Edwards Lifesciences by 908.3% in ...
12/13/2021 Raymond James Boosts Edwards Lifesciences (NYSE:EW) Price Target to $134.00 Edwards Lifesciences (NYSE:EW) had its price objective increased by Raymond James from $127.00 to $134.00 in a report issued on Friday, The Fly reports. The brokerage currently has an outperform rating on the medical research company‚Aos stock.Several other equities research analysts also recently issued reports on the company. Royal Bank of Canada assumed coverage on Edwards Lifesciences in a report on Thursday. They issued an outperform rating ...
10/11/2021 Edwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 11,050 Shares - Stock Observer Edwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. sold 11,050 shares of the firm‚Aos stock in a transaction dated Friday, October 8th. The shares were sold at an average price of $110.49 ... last released its earnings results on Thursday, July 29th. The medical research company reported $0.64 earnings per share (EPS) for the quarter, beating analysts‚Ao consensus estimates of $0.55 by $0.09. Edwards Lifesciences had a ...
10/9/2021 Edwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 11,050 Shares Edwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. sold 11,050 shares of the stock in a transaction on Friday, October 8th. The shares were sold at an average price of $110.49, for a ... announced its quarterly earnings results on Thursday, July 29th. The medical research company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.09. Edwards Lifesciences had a return ...
9/30/2021 Edwards Lifesciences Co. (NYSE:EW) Shares Acquired by SeaCrest Wealth Management LLC SeaCrest Wealth Management LLC increased its position in Edwards Lifesciences Co. (NYSE:EW) by 1.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,632 shares of the medical research company‚Aos stock after acquiring an additional 120 shares during the period. SeaCrest Wealth Management LLC‚Aos holdings in Edwards Lifesciences were worth $894,000 at the end ...
9/30/2021 SeaCrest Wealth Management LLC Boosts Stake in Edwards Lifesciences Co. (NYSE:EW) - WKRB News SeaCrest Wealth Management LLC increased its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 1.4% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,632 shares of the medical research company‚Aos stock after purchasing an additional 120 shares during the period. SeaCrest Wealth Management LLC‚Aos holdings in Edwards Lifesciences were worth $894,000 at the end of the most ...
9/27/2021 $0.53 EPS Expected for Edwards Lifesciences Co. (NYSE:EW) This Quarter - Slater Sentinel Wall Street analysts expect Edwards Lifesciences Co. (NYSE:EW) to report earnings of $0.53 per share for the current quarter, Zacks reports. Nine analysts have issued estimates for Edwards Lifesciences‚Ao earnings, with the highest ... last released its earnings results on Thursday, July 29th. The medical research company reported $0.64 EPS for the quarter, topping analysts‚Ao consensus estimates of $0.55 by $0.09. Edwards Lifesciences had a return on equity ...
9/22/2021 Edwards Lifesciences Co. (NYSE:EW) Shares Purchased by Deutsche Bank AG Deutsche Bank AG boosted its position in Edwards Lifesciences Co. (NYSE:EW) by 6.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,092,369 shares of the medical research company‚Aos stock after acquiring an additional 133,535 shares during the quarter. Deutsche Bank AG‚Aos holdings in Edwards Lifesciences were worth $216,706,000 at the end of the ...
9/20/2021 Baxter Bros Inc. Has $9.59 Million Position in Edwards Lifesciences Co. (NYSE:EW) The Markets Daily Baxter Bros Inc. lifted its stake in Edwards Lifesciences Co. (NYSE:EW) by 0.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 92,608 shares of the medical research company‚Aos stock after acquiring an additional 403 shares during the quarter. Edwards Lifesciences makes up 1.5% of Baxter Bros Inc.‚Aos portfolio, making the stock its 21st biggest holding. Baxter ...
9/20/2021 Rafferty Asset Management LLC Raises Stake in Edwards Lifesciences Co. (NYSE:EW) American Banking News Rafferty Asset Management LLC grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 7.0% during the 2nd its most recent 13F filing with the SEC. The institutional investor owned 13,798 shares of the medical research company‚Aos stock after purchasing an additional 908 shares during the period. Rafferty Asset Management LLC‚Aos holdings in Edwards Lifesciences were worth $1,429,000 at the end of the most recent reporting ...
9/18/2021 Mercer Global Advisors Inc. ADV Sells 862 Shares of Edwards Lifesciences Co. (NYSE:EW) American Banking News Mercer Global Advisors Inc. ADV lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 2.0% during the second its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,972 shares of the medical research company‚Aos stock after selling 862 shares during the quarter. Mercer Global Advisors Inc. ADV‚Aos holdings in Edwards Lifesciences were worth $4,347,000 at the end of the most recent ...
9/18/2021 Mercer Global Advisors Inc. ADV Has $4.35 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) Mercer Global Advisors Inc. ADV decreased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW) by 2.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,972 shares of the medical research company‚Aos stock after selling 862 shares during the quarter. Mercer Global Advisors Inc. ADV‚Aos holdings in Edwards Lifesciences were worth $4,347,000 at the ...
9/18/2021 Mercer Global Advisors Inc. ADV Sells 862 Shares of Edwards Lifesciences Co. (NYSE:EW) - WKRB News Mercer Global Advisors Inc. ADV lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,972 shares of the medical research company‚Aos stock after selling 862 shares during the quarter. Mercer Global Advisors Inc. ADV‚Aos holdings in Edwards Lifesciences were worth $4,347,000 at the end of ...
9/18/2021 Bluesphere Advisors LLC Lowers Stock Position in Edwards Lifesciences Co. (NYSE:EW) The Markets Daily Bluesphere Advisors LLC lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW) by 39.7% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 2,081 shares of the medical research company‚Aos stock after selling 1,369 shares during the period. Bluesphere Advisors LLC‚Aos holdings in Edwards Lifesciences were worth $216,000 as of its most recent SEC filing.A number of other institutional investors have also recently made ...
9/18/2021 Bluesphere Advisors LLC Sells 1,369 Shares of Edwards Lifesciences Co. (NYSE:EW) - Stock Observer Bluesphere Advisors LLC cut its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 39.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,081 shares of the medical research company‚Aos stock after selling 1,369 shares during the quarter. Bluesphere Advisors LLC‚Aos holdings in Edwards Lifesciences were worth $216,000 as of its most recent filing with ...
9/16/2021 Edwards Lifesciences Co. (NYSE:EW) Shares Purchased by CWM Advisors LLC - Transcript Daily CWM Advisors LLC lifted its holdings in Edwards Lifesciences Co. (NYSE:EW) by 9.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,374 shares of the medical research company‚Aos stock after acquiring an additional 4,196 shares during the quarter. Edwards Lifesciences accounts for 0.7% of CWM Advisors LLC‚Aos holdings, making the stock its 24th biggest position ...
9/16/2021 Inverness Counsel LLC NY Invests $752,000 in Edwards Lifesciences Co. (NYSE:EW) - The Cerbat Gem Inverness Counsel LLC NY bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW) in the second quarter, HoldingsChannel reports. The institutional investor bought 7,265 shares of the medical research company‚Aos stock, valued at approximately $752,000.Other hedge funds have also recently added to or reduced their stakes in the company. Baldrige Asset Management LLC bought a new stake in shares of Edwards Lifesciences in the second ...
9/16/2021 Inverness Counsel LLC NY Acquires Shares of 7,265 Edwards Lifesciences Co. (NYSE:EW) - Watch List News Inverness Counsel LLC NY bought a new position in shares of Edwards Lifesciences Co. (NYSE:EW) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 7,265 shares of the medical research company‚Aos stock, valued at approximately $752,000.Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Janus Henderson ...